MLchartDataset catalogue

Trastuzumab and hyaluronidase

Term · Oncology and biomedicine · MLC-T-ONC-008873

A combination of two drugs used alone or with other drugs to treat adults with certain types of HER2-positive breast cancer. Trastuzumab binds to a protein called HER2, which is found on some cancer cells. This may help the immune system kill cancer cells. Hyaluronidase allows trastuzumab to be given by injection under the skin. Trastuzumab and hyaluronidase can be given in less time than trastuzumab alone, which is given as an infusion. Also called Herceptin Hylecta.

Table 1. Record
IdentifierMLC-T-ONC-008873
FieldOncology and biomedicine
SynonymsHerceptin Hylecta
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008873",
  "term": "Trastuzumab and hyaluronidase",
  "field": "Oncology and biomedicine",
  "definition": "A combination of two drugs used alone or with other drugs to treat adults with certain types of HER2-positive breast cancer. Trastuzumab binds to a protein called HER2, which is found on some cancer cells. This may help the immune system kill cancer cells. Hyaluronidase allows trastuzumab to be given by injection under the skin. Trastuzumab and hyaluronidase can be given in less time than trastuzumab alone, which is given as an infusion. Also called Herceptin Hylecta.",
  "synonyms": [
    "Herceptin Hylecta"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/trastuzumab-and-hyaluronidase/"
}

Record 16,659 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.